Conditions: Pelvic Inflammatory Disease
Keywords: Uncomplicated pelvic inflammatory disease
Allocation: RANDOMIZED | Intervention model: PARALLEL
Enrollment: 460
Healthy volunteers: no

Brief summary:
To assess the efficacy and safety of oral moxifloxacin compared to oral levofloxacin plus oral metronidazole in uncomplicated pelvic inflammatory disease (PID)

Detailed description:

Arms:
arm 1: Moxifloxacin (Avelox, BAY12-8039) 400 mg by mouth (PO) once daily for 14 days arm 2: Levofloxacin 500 mg by mouth (PO) once daily for 14 days plus Metronidazole 500 mg (PO) twice daily for 14 days

Interventions: intervention 1: Moxifloxacin (Avelox, BAY12-8039) intervention 2: Levofloxacin & Metronidazole
Intervention descriptions: intervention 1: Moxifloxacin (Avelox, BAY12-8039) 400 mg by mouth (PO) once daily for 14 days intervention 2: Levofloxacin 500 mg by mouth (PO) once daily for 14 days plus Metronidazole 500 mg (PO) twice daily for 14 days

Protocol document: